Interim Guidance on Monkeypox Exposure for Pregnant People

Authors: Vanessa Poliquin, Andrea Atkinson, Isabelle Boucoiran, Chelsea Elwood, Julie van Schalkwyk, Mark H. Yudin, Deborah Money, on behalf of the SOGC’s Infectious Diseases Committee

Original: June 3rd, 2022
Revised: June 9th, 2022
Reaffirmed: November 2nd, 2022


  1. Smallpox vaccine should be recommended as post-exposure prophylaxis (PEP) to pregnant women who are exposed to monkeypox in accordance with jurisdictional-specific direction on categories of exposures that qualify for PEP.
  2. Pregnant individuals with suspected monkeypox should be managed by an interdisciplinary team as there is a paucity of data on monkeypox in pregnancy, but signals of profound morbidity for the pregnancy exist.

Read the statement HERE.

The Public Health Agency of Canada (PHAC) Monkeypox Stakeholder Toolkit

Resources will be updated as new information on monkeypox in Canada becomes available.

You can find the toolkit here.

The latest information including on Canadian case numbers is available on

Physician touching an electronic medical record on a tablet